OSS (OSS) Q3 2025: Revenue Surges 37% as Defense and Commercial Pipelines Expand
OSS delivered a breakout Q3, with both defense and commercial wins fueling a 37% revenue jump and margin expansion. The company’s repositioned go-to-market and product mix are driving sustained operating leverage, while a $12.5 million capital raise strengthens the balance sheet for future growth. Management’s raised guidance and robust backlog signal confidence, yet government shutdown risk and commercial ramp timing remain key watchpoints for 2026.
Summary
- Defense and Commercial Demand Accelerates: Backlog and bookings momentum reflect multi-year program wins across both segments.
- Margin Expansion Driven by Product Mix: Higher-value, enterprise-class compute solutions lift gross margin profile.
- Forward Visibility Anchored by Raised Guidance: Full-year outlook increased, supported by robust pipeline and recent capital raise.
Performance Analysis
OSS posted consolidated revenue of $18.8 million, up 36.9% year-over-year, with the OSS segment itself growing 43.4%. This growth was driven by strong execution on defense contracts—particularly the P-8 Poseidon program, which has now surpassed $50 million in lifetime revenue—and expanding commercial opportunities, including medical imaging and aerospace. The Bresner segment, OSS’s European arm, contributed $2.3 million in additional revenue, benefiting from both end-market recovery and foreign exchange tailwinds.
Gross margin improved to 35.7% at the consolidated level, with the OSS segment reaching 45.6% thanks to a favorable product mix and operational efficiency. Both operating segments delivered positive EBITDA, and OSS returned to GAAP net profitability, a significant turnaround from last year’s losses. Operating expenses rose 22%, mainly due to targeted R&D investments in next-generation products, but this spend is positioning the company for future commercial and defense wins. The recent $12.5 million capital raise provides further flexibility to pursue working capital needs and strategic M&A.
- Backlog and Book-to-Fill Strength: The OSS segment’s trailing 12-month book-to-fill ratio hit 1.4, indicating sustained demand visibility.
- Bresner Outperformance: Bresner’s margin improved 400 basis points, with growth in industrial markets and some FX benefit.
- Profitability Milestone: Positive consolidated EBITDA and net income mark a key inflection point in OSS’s turnaround strategy.
Cash flow from operations was negative year-to-date, due to working capital tied up in receivables from the revenue ramp, but management expects positive cash flow in Q4 as shipments convert to collections.
Executive Commentary
"OSS delivered a strong third quarter with significant consolidated revenue growth, higher gross margin, and positive EBITDA net income. Our third quarter and year-to-date performance underscored the solid foundation we have built as we capitalized on increasing demand from both defense and commercial customers for our rugged enterprise class compute solutions."
Mike Knowles, President and CEO
"We achieved robust top line growth, increasing revenue year over year by 36.9% at a consolidated level, and by 43.4% for the OSS segment. These results were supported by strong gross margins, reflecting the value that customers place on our differentiated technology."
Dan, Chief Financial Officer
Strategic Positioning
1. Multi-Year Defense Platform Expansion
OSS’s core growth engine remains its defense business, where multi-year sole source contracts like the P-8 Poseidon and emerging Army combat vehicle programs provide recurring revenue and pipeline visibility. The company’s solutions for high-density, ruggedized compute at the edge are increasingly integral to defense modernization, including AI, machine learning, and sensor fusion workloads.
2. Commercial Market Diversification
OSS is making tangible inroads into commercial verticals, including medical imaging and commercial aerospace. Notable wins—a five-year, $25 million medical imaging contract and a $6 million cabin systems order—validate the applicability of OSS’s enterprise-class compute in regulated, performance-critical commercial environments. The company is also piloting new products (like the Ponto GPU expansion system) with data center customers, signaling potential for future commercial revenue streams.
3. Technology and Product Investment
R&D investments are focused on next-generation solutions, such as PCI Gen 6 systems and high-wattage GPU accelerators, to address the growing demand for performance-intensive compute. OSS’s product launches and conference participation (AUSA, NVIDIA GTC) are deepening its ecosystem relationships and positioning the company as a partner of choice for AI-centric workloads at the edge.
4. Balance Sheet and Capital Allocation
The $12.5 million capital raise post-quarter end enhances OSS’s financial flexibility, supporting working capital for growth and enabling a disciplined M&A strategy in 2026. With positive EBITDA generation, the company is positioned to reinvest in both organic and inorganic growth levers.
5. Operational Discipline and Execution
OSS’s operational improvements—especially in supply chain management and product mix optimization—are driving margin gains and delivery reliability, even as government shutdowns and macro uncertainty introduce timing risks. Management’s ability to maintain backlog and execute shipments despite external headwinds is a key differentiator.
Key Considerations
OSS’s Q3 marks a pivotal moment, reflecting not only strong execution but also the fruits of a multi-year repositioning across leadership, product, and go-to-market strategy. The company’s ability to balance defense stability with commercial expansion will be critical for sustaining momentum into 2026.
Key Considerations:
- Defense Backlog and Sole Source Status: OSS’s role as a sole source provider on key platforms insulates near-term demand, but government shutdowns could delay new awards.
- Commercial Ramp Timing: While commercial bookings are building, management acknowledged timing has lagged initial expectations, pushing some upside into 2026.
- Gross Margin Variability: Product mix and program lifecycle will continue to cause quarter-to-quarter margin swings, though the company targets mid-30s to low-40s percent for the OSS segment.
- R&D Investment Payoff: Elevated R&D spend in 2025 is expected to normalize in 2026, but realization of new program wins will be a key proof point.
- Cash Flow Inflection: Q4 is expected to be cash flow positive, with receivables conversion and shipment timing as key drivers.
Risks
Timing risk from the ongoing U.S. government shutdown remains the most material near-term headwind, potentially delaying new contract awards and impacting revenue conversion into 2026. Commercial market expansion, while promising, is subject to execution risk and broader macroeconomic uncertainty, especially in Europe. Gross margin variability and reliance on a handful of large programs also introduce concentration risk, which investors should monitor as OSS pursues diversification.
Forward Outlook
For Q4 2025, OSS guided to:
- Continued strength in both revenue and profitability, with Q4 revenue expected to be in line with or above Q3.
- OSS segment gross margin at the upper end of the mid-30s to low-40s percent range.
For full-year 2025, management raised guidance:
- Consolidated revenue of $63 million to $65 million (prior: $59 million to $61 million)
- OSS segment revenue of $30 million to $32 million, up 22% to 30% year-over-year
- Positive consolidated EBITDA reaffirmed
Management highlighted:
- Backlog covers 2025 guidance, with additional bookings to build 2026 visibility
- Commercial pipeline expected to accelerate into 2026 as new product placements mature
Takeaways
OSS is executing a multi-year turnaround, with Q3 results validating its defense franchise and early commercial traction. Margin gains and capital flexibility provide a solid foundation, but timing of government awards and commercial ramp will define the next leg of growth.
- Defense and Commercial Balance: Sustained defense backlog and new commercial wins are diversifying revenue streams and reducing cyclicality.
- Margin and Cash Flow Progression: Operating leverage and gross margin expansion are translating to positive EBITDA and net income, though working capital swings merit attention.
- 2026 Watchpoints: Investors should monitor the pace of commercial order conversion, government shutdown resolution, and R&D-driven product adoption as core drivers of next year’s outlook.
Conclusion
OSS’s Q3 2025 performance demonstrates the payoff from strategic repositioning, with robust revenue growth, margin expansion, and a strengthened balance sheet. The raised outlook and expanding pipeline set a constructive tone, but execution on commercial ramp and government contract timing will determine if OSS can sustain this momentum into 2026.
Industry Read-Through
OSS’s results reflect broader tailwinds in high-performance edge computing, particularly as AI and sensor fusion workloads proliferate in both defense and commercial markets. The company’s traction in ruggedized, enterprise-class compute is a signal for peers that demand is shifting toward solutions that bridge data center capabilities with field reliability. The ongoing government shutdown highlights vulnerability for all defense IT vendors to funding cycles, while commercial verticals like medical imaging and aerospace are emerging as attractive adjacent markets for edge compute providers. Investors in the sector should watch for similar margin and backlog dynamics as product mix shifts toward higher-value, AI-centric solutions.